Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HAEMONETICS CORP | EVP and General Counsel | Common Stock | 31.3K | $2.77M | $88.57 | May 29, 2024 | Direct |
HAEMONETICS CORP | EVP and General Counsel | Non-qualified Stock Option (Right to Buy) | 9.18K | May 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HAE | HAEMONETICS CORP | May 28, 2024 | 4 | -$2.27M | 4 | May 29, 2024 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 17, 2024 | 5 | -$318K | 4 | May 21, 2024 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 15, 2024 | 3 | -$177K | 4 | May 17, 2024 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Oct 20, 2023 | 1 | -$17.5K | 4 | Oct 24, 2023 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 18, 2023 | 1 | -$295K | 4 | May 19, 2023 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 15, 2023 | 3 | -$39.8K | 4 | May 17, 2023 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 12, 2023 | 1 | -$18K | 4 | May 16, 2023 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Oct 24, 2022 | 1 | -$14.5K | 4 | Oct 26, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Sep 19, 2022 | 7 | -$531K | 4 | Sep 21, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Sep 15, 2022 | 8 | -$1.43M | 4 | Sep 19, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Jun 13, 2022 | 1 | -$17.3K | 4 | Jun 15, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 19, 2022 | 1 | -$193K | 4 | May 23, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 16, 2022 | 3 | -$11K | 4 | May 18, 2022 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Oct 25, 2021 | 1 | -$8.63K | 4 | Oct 27, 2021 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Jun 14, 2021 | 1 | -$11.7K | 4 | Jun 16, 2021 | EVP and General Counsel |
HAE | HAEMONETICS CORP | Jun 7, 2021 | 1 | -$24.3K | 4 | Jun 9, 2021 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 18, 2021 | 4 | -$12.1K | 4 | May 20, 2021 | EVP and General Counsel |
HAE | HAEMONETICS CORP | May 17, 2021 | 1 | -$11.4K | 4 | May 18, 2021 | EVP and General Counsel |